| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytosine methylation 0.974443772318407 2.590690529133308 0.0095783583655713 0.996894919163262 1.0 5 P48735 1 |
| Vitamin a and carotenoid metabolism 0.9093609522798332 2.33603084684506 0.0194896339083507 0.9999925644402172 1.0 5 O94788,P09455 2 |
| Histone modifications 0.8494053181109162 2.094803773992018 0.0361884394991351 0.9999999997515272 1.0 5 Q9H7B4,Q03164 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.7542978001769017 2.0675383926483413 0.0386834504116835 0.9999999999475372 1.0 14 O43772,Q9BY49,P11310,P23786 4 |
| Statin inhibition of cholesterol production 0.8207185630854805 1.9771859593524783 0.0480206141031791 0.99999999999985 1.0 5 P35610,Q8WTV0 2 |
| Ketogenesis and ketolysis 0.8118361451462347 1.940488937052801 0.0523202973705052 0.99999999999999 1.0 5 O43772,P23786 2 |
| Resistin as a regulator of inflammation 0.7397321551225405 1.8926041395343272 0.0584105328614232 0.9999999999999998 1.0 6 O14920 1 |
| Type ii diabetes mellitus 0.8218663917924612 1.8622637449513884 0.0625659231441657 1.0 1.0 4 O00330 1 |
| Modulators of tcr signaling and t cell activation 0.6926823599727142 1.7051791377508367 0.088161019658721 1.0 1.0 10 O96000,P62993,O14920 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.8572347017758084 1.6328716775631391 0.1024959879811564 1.0 1.0 3 P31751 1 |
| Striated muscle contraction pathway 0.7313825958827227 1.60263482846684 0.109015299675067 1.0 1.0 5 P09493 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.6465999618231933 1.5030636804899338 0.1328226234279841 1.0 1.0 12 P13674,O15460,Q32P28,Q96AY3 4 |
| 15q112 copy number variation syndrome 0.8044553121164882 1.429648115574077 0.1528180385182564 1.0 1.0 3 Q06787 1 |
| Sarscov2 and covid19 pathway 0.7794766700688127 1.3330902774293725 0.1825021796050476 1.0 1.0 3 Q8WTV0 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.6908163265306217 1.324368331412736 0.1853807468087867 1.0 1.0 4 O60725,Q03252,P02545 3 |
| Cerebral organic acidurias including diseases 0.6624722067416268 1.3073059019852415 0.1911088405646153 1.0 1.0 5 P48735 1 |
| Translation factors 0.4525273147302886 1.305047998438237 0.1918765042383396 1.0 1.0 37 O75153,P55010,P23588,O75822,Q15056,O43432 6 |
| Allograft rejection 0.5979402507605309 1.2463243084755578 0.2126453570677811 1.0 1.0 10 P04439,Q9BY49,P08670 3 |
| Glucocorticoid receptor pathway 0.5983515762021806 1.2409669701746593 0.2146179508729027 1.0 1.0 6 P27105,Q99576 2 |
| Endochondral ossification with skeletal dysplasias 0.5938686982714763 1.219978289080673 0.2224731053170976 1.0 1.0 6 P22413,Q96QD8 2 |
| Endochondral ossification 0.5938686982714763 1.219978289080673 0.2224731053170976 1.0 1.0 6 P22413,Q96QD8 2 |
| Nanomaterial induced apoptosis 0.5899795475934279 1.201768036124522 0.2294534127850198 1.0 1.0 6 O95831 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.5818726770117659 1.162557324950184 0.2450091536811789 1.0 1.0 8 O14920,Q9P0J0,Q96RT1 3 |
| Cellular proteostasis 0.6485460581368265 1.1490345592597253 0.2505417305620876 1.0 1.0 4 O15212 1 |
| Neuroinflammation 0.6409713505892467 1.117700701536461 0.2636948430498429 1.0 1.0 4 P00403 1 |
| Oxidation by cytochrome p450 0.61812871532857 1.1163359226487586 0.2642783704560498 1.0 1.0 5 Q16850,O43169 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5586102559158845 1.0918512998410494 0.2748984663633289 1.0 1.0 15 Q13547,O60725,P55209,Q9Y2U8,Q9UPY3,P50402 6 |
| Notch signaling 0.5668092018226075 1.0906410341188135 0.2754308662002231 1.0 1.0 8 Q13547,O14641 2 |
| Familial partial lipodystrophy fpld 0.5660402677723659 1.0875922113148158 0.2767751706757515 1.0 1.0 7 O60725,P31751 2 |
| Retinoblastoma gene in cancer 0.3503939076466438 1.0714434795046108 0.2839700716395246 1.0 1.0 45 Q13547,P24941,P15927,P31350,Q9UQE7,Q16204,Q9Y619,Q14566,P16949,P33991,Q14527,Q07864,P09455 13 |
| Ranklrank signaling pathway 0.5538696531975651 1.056302976783794 0.2908298164122549 1.0 1.0 14 O14920,P31751 2 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.5566635790798934 1.048632566631052 0.2943472611351092 1.0 1.0 11 P31751,Q05397 2 |
| Fatty acid betaoxidation 0.5281548773161409 1.0333996707398376 0.3014169005021281 1.0 1.0 21 O43772,P35610,P23786,P11310 4 |
| Nodlike receptor nlr signaling pathway 0.9163834126444504 1.021000905271114 0.3072540098134899 1.0 1.0 2 O14920 1 |
| Influence of laminopathies on wnt signaling 0.5501120813070318 1.011284665404978 0.3118802033233101 1.0 1.0 9 O60725,P50402,Q9UPY3 3 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.5405570605288305 0.9695008213952409 0.3322953705894096 1.0 1.0 11 O14920,P31751 2 |
| Small cell lung cancer 0.5389671528037622 0.9617136772370682 0.3361934500493408 1.0 1.0 11 O14920,P31751,Q05397 3 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.5376566149920142 0.9596210738202442 0.3372459588780465 1.0 1.0 12 P62993,O14920 2 |
| Overview of nanoparticle effects 0.6744506362065011 0.930278773346834 0.3522267652083604 1.0 1.0 3 Q05397 1 |
| Electron transport chain oxphos system in mitochondria 0.344906026556927 0.9108078688484073 0.3623966156895588 1.0 1.0 52 P00403,P03886,O96000,P00846 4 |
| Congenital generalized lipodystrophy cgl 0.8834126444595396 0.9063775981185316 0.3647360258327654 1.0 1.0 2 P31751 1 |
| Mecp2 and associated rett syndrome 0.5108039281914718 0.8963582788331376 0.3700614424176067 1.0 1.0 19 Q13547,Q9UQE7,P21359,Q13451,P35637,P16220,P52597,Q00013,P67809 9 |
| Cholesterol biosynthesis with skeletal dysplasias 0.5207820533275129 0.8796429034228349 0.3790527891421289 1.0 1.0 6 Q16850,Q15392 2 |
| Smc1smc3 role in dna damage cornelia de lange syndrome 0.5203507057468479 0.8734298138579067 0.3824288465031169 1.0 1.0 7 Q92878,O60934,Q9UQE7,O60216 4 |
| Novel intracellular components of rigilike receptor rlr pathway 0.5206706504102402 0.8721009215512501 0.3831533234619151 1.0 1.0 8 O14920 1 |
| Type 2 papillary renal cell carcinoma 0.5204532453656199 0.8710819512846842 0.3837094081919026 1.0 1.0 8 Q92733 1 |
| Transcription cofactors ski and skil protein partners 0.5734866524451899 0.8423525858154604 0.3995906244825211 1.0 1.0 4 Q13547 1 |
| Arachidonate epoxygenase epoxide hydrolase 0.8599592114208026 0.8265202008204215 0.4085090636806561 1.0 1.0 2 P34913 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.5481403804002072 0.8191140490653668 0.4127213470630173 1.0 1.0 5 Q05397 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4756473296605938 0.804978001847172 0.4208323742193416 1.0 1.0 24 Q15392,Q15800,Q16850,Q14534,P48449,P35610 6 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4998133802825016 0.7839529062610913 0.4330677440932593 1.0 1.0 6 Q13547,Q8IXH7 2 |
| Tolllike receptor signaling pathway 0.4954475791617559 0.7530566849586853 0.4514158517034294 1.0 1.0 12 O14920 1 |
| Tryptophan metabolism 0.4899995341441488 0.7405718969255869 0.4589530529698389 1.0 1.0 15 Q15392,P35610,O94788 3 |
| Oxidative phosphorylation 0.4316722859693618 0.7282584665466935 0.4664553817405856 1.0 1.0 30 O96000,P00846 2 |
| Cell migration and invasion through p75ntr 0.5207944789036931 0.7066877683648055 0.4797605324404284 1.0 1.0 5 P31751 1 |
| Dna mismatch repair 0.4798799749291141 0.7064186190310702 0.4799278454400852 1.0 1.0 17 P35250,P15927,Q9UQ84,Q9NRF9,Q07864 5 |
| Pdgfrbeta pathway 0.4829967670527672 0.7026682612754025 0.4822625114854184 1.0 1.0 7 P62993,P42224,P19525,P40763 4 |
| Wnt signaling in kidney disease 0.6086773237960698 0.6890672714631045 0.490780934812385 1.0 1.0 3 O14641 1 |
| Wnt signaling pathway and pluripotency 0.4791294666888785 0.6774319587948954 0.4981319269659934 1.0 1.0 13 P63151,P25054,O14641,P30154,O60716 5 |
| Prion disease pathway 0.4788000974392964 0.6736725019752801 0.5005195478003064 1.0 1.0 10 P16220,Q9UQE7,Q05397 3 |
| Cardiac hypertrophic response 0.4755592989862426 0.6578833264900751 0.5106131053918275 1.0 1.0 11 O14920 1 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.5062624482468663 0.6483562882721396 0.5167545354379188 1.0 1.0 5 O60934 1 |
| Zinc homeostasis 0.8052345343303886 0.6477314224592158 0.5171586769710099 1.0 1.0 2 Q8TAD4 1 |
| Met in type 1 papillary renal cell carcinoma 0.4573552057052339 0.6400315268194877 0.5221521032338603 1.0 1.0 21 Q14241,P31751,Q92733 3 |
| Airway smooth muscle cell contraction 0.5036742043335831 0.6380900092407386 0.5234150897233816 1.0 1.0 5 P61586 1 |
| Chemokine signaling pathway 0.4636696027910326 0.6338895020306554 0.5261529371672162 1.0 1.0 18 P42224,O14920,P41240,P62993,P31751,Q05397 6 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.5012576566649193 0.6285408927143578 0.5296496670195627 1.0 1.0 5 P62942 1 |
| Tgfbeta receptor signaling 0.5012576566649193 0.6285408927143578 0.5296496670195627 1.0 1.0 5 P62942 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4615342443645489 0.5980815755837681 0.5497855032565389 1.0 1.0 9 Q05397 1 |
| Mthfr deficiency 0.4575254852342512 0.5902927368171946 0.5549944079669231 1.0 1.0 7 Q96KQ7,P49419 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4901143734180509 0.5849868501615817 0.5585565587318628 1.0 1.0 5 O14641 1 |
| Pparalpha pathway 0.4553040162414283 0.5807006496007472 0.5614422238412105 1.0 1.0 7 P23786 1 |
| White fat cell differentiation 0.5769817732260639 0.5794058848374386 0.562315334244663 1.0 1.0 3 P16220 1 |
| Insulin signaling 0.3360652749623322 0.5647064450365592 0.5722734497449036 1.0 1.0 40 P22413,P10586,O14920,Q12965,P62993,P31751 6 |
| Ras signaling 0.4206285781396652 0.5605776014571109 0.5750855243414645 1.0 1.0 27 O14920,Q13177,Q13043,P61586,Q9UQ13,P21359,Q9UJF2,P62993,P11233,P31751 10 |
| Homologous recombination 0.4446584622875356 0.5424423490642235 0.587513812475952 1.0 1.0 6 O60934 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.488584798255455 0.5196616742859307 0.6032994037898765 1.0 1.0 4 Q9NT62 1 |
| Cholesterol biosynthesis pathway 0.4432853324153217 0.5118482172076464 0.6087572416324358 1.0 1.0 14 Q16850,P48449,Q15800,Q14534 4 |
| Nanoparticlemediated activation of receptor signaling 0.4334231361561087 0.4884070844969277 0.6252615247931994 1.0 1.0 7 Q05397 1 |
| Adipogenesis 0.4370552345494539 0.4827262735874332 0.6292901054039124 1.0 1.0 13 P42224,P43490,P40763,Q16822,P14174,P17096,O00767,P16220,P02545 9 |
| Nonalcoholic fatty liver disease 0.2950254022037474 0.4574787197861919 0.6473269944169706 1.0 1.0 49 O14920,P00403,O96000,P31751 4 |
| Ethanol effects on histone modifications 0.4182433822844779 0.4093826878740529 0.68225884236244 1.0 1.0 10 Q13547,O94788 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4197863854339154 0.4078287628327833 0.6833993953925823 1.0 1.0 13 P55010 1 |
| Pi3kakt signaling pathway 0.3504723195375113 0.3937788603522019 0.69374431304316 1.0 1.0 35 P24941,P63151,P30154,O14920,P23588,P62993,P13807,P31751,Q05397 9 |
| Transcription factor regulation in adipogenesis 0.7141400407885826 0.3857367362577871 0.6996916528624242 1.0 1.0 2 P16220 1 |
| Neural crest cell migration during development 0.4087338019756406 0.382796135529217 0.701870927057457 1.0 1.0 8 P61586,P31751 2 |
| Complement system in neuronal development and plasticity 0.4103323511422787 0.3735071113648273 0.7087710535719471 1.0 1.0 11 P10909 1 |
| Proteasome degradation 0.30419237085326 0.3698969005055856 0.7114593109507301 1.0 1.0 41 P28070,P01889,Q99436,P28072,O00231,P49721,P28074,P04439 8 |
| Mitochondrial gene expression 0.4215068541467414 0.3398458030431667 0.7339726527404715 1.0 1.0 5 Q9P2K5 1 |
| Neural crest cell migration in cancer 0.3970623252813996 0.3319739904711241 0.7399088989208709 1.0 1.0 9 P61586,P31751 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3712416741433469 0.3289801794543275 0.7421706694492498 1.0 1.0 29 P48449,Q14534,Q8WTV0 3 |
| G1 to s cell cycle control 0.3824818504237683 0.3288703780161878 0.7422536649463245 1.0 1.0 26 P24941,Q13416,P15927,Q9Y619,Q14566,P33991,P16220,Q07864 8 |
| Mitochondrial complex iv assembly 0.3979019550742302 0.3185054481338973 0.7501015626581373 1.0 1.0 13 P00403,Q7KZN9 2 |
| Epo receptor signaling 0.3869500768463225 0.3178867675379216 0.750570830356472 1.0 1.0 6 P62993 1 |
| Il9 signaling pathway 0.3869500768463225 0.3178867675379216 0.750570830356472 1.0 1.0 6 P62993 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3882450452753125 0.2995743563804206 0.7645018469227389 1.0 1.0 9 Q13257,Q8WVM7 2 |
| Cytosolic dnasensing pathway 0.3886236353535507 0.2950421015522321 0.7679617180635576 1.0 1.0 10 P62875,O14920,P52434 3 |
| Progeriaassociated lipodystrophy 0.3858603223661155 0.2910153740161117 0.7710395613790975 1.0 1.0 9 P20700,O60725,Q03252,P02545 4 |
| Tnfalpha signaling pathway 0.3883164484225755 0.2907543077408001 0.7712392333656473 1.0 1.0 20 Q9NR28,O14920 2 |
| Il4 signaling pathway 0.3830323607264927 0.2749225814361292 0.7833757179066119 1.0 1.0 10 O14920 1 |
| Embryonic stem cell pluripotency pathways 0.3809527012865613 0.2544152428612629 0.799174776203587 1.0 1.0 13 P31751,O14641 2 |
| T cell receptor and costimulatory signaling 0.3993197278911547 0.2456870940702403 0.8059244634783516 1.0 1.0 4 P48729,P19174,P49840 3 |
| Apoptosis modulation and signaling 0.3788718011104676 0.2438462786869643 0.8073498767199561 1.0 1.0 18 O14920 1 |
| Pathways affected in adenoid cystic carcinoma 0.3771700359492904 0.2407898232714824 0.8097180174511089 1.0 1.0 13 Q9UBU8 1 |
| Dna irdamage and cellular response via atr 0.3463261670827866 0.2407700223509129 0.8097333649050271 1.0 1.0 31 P24941,P15927,Q92878,O60934,Q9UQ84 5 |
| Acute viral myocarditis 0.3781308173474749 0.2397916315655938 0.8104917947768273 1.0 1.0 15 P16220,Q9NRG0,P42224 3 |
| Tcell activation sarscov2 0.3769082922300392 0.237094274795541 0.8125836538094791 1.0 1.0 14 P62993,O14920 2 |
| Serotonin receptor 467 and nr3c signaling 0.3860802399728152 0.2345002802235785 0.8145966156659767 1.0 1.0 5 P49137 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.6454792658055751 0.2314546976215779 0.8169615759775923 1.0 1.0 2 P42224 1 |
| 22q112 copy number variation syndrome 0.3367463735915843 0.213434007620514 0.8309884573020314 1.0 1.0 32 Q96DF8,O94788 2 |
| Notch signaling pathway 0.3651126945266924 0.2082723328803414 0.8350163331243923 1.0 1.0 11 Q96T58,Q13547 2 |
| Micrornas in cardiomyocyte hypertrophy 0.3690657020079805 0.2080841344952284 0.8351632748676516 1.0 1.0 19 O14920,P31751 2 |
| Tcell receptor tcr signaling pathway 0.3693089070325095 0.2071028951958437 0.8359295010774637 1.0 1.0 18 P62993,O14920,P08670 3 |
| Il10 antiinflammatory signaling pathway 0.3747023400980533 0.2045440629980579 0.8379283624715617 1.0 1.0 5 P09601 1 |
| Estrogen receptor pathway 0.6288239292997884 0.2008722539794609 0.8407984636160757 1.0 1.0 2 Q15067 1 |
| Apoptosis 0.3638188774389061 0.1990546960565932 0.8422199593045008 1.0 1.0 12 O14920 1 |
| Type ii interferon signaling ifng 0.368359802848105 0.1887289861454884 0.8503052321682969 1.0 1.0 5 P01889 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3581961540464858 0.1861389569614222 0.8523357924878376 1.0 1.0 11 P31751 1 |
| Leptininsulin signaling overlap 0.6148878314072121 0.1774532435453175 0.8591523885532215 1.0 1.0 2 P40763 1 |
| Glioblastoma signaling pathways 0.3594530237112588 0.1741861493150566 0.8617191703852058 1.0 1.0 15 P24941,P31751 2 |
| Ccl18 signaling pathway 0.3456291541007457 0.1687580273153205 0.8659869740681732 1.0 1.0 8 Q86UE4,P42224,P00403,P08670 4 |
| Dna repair pathways full network 0.2842141513314645 0.1681752211568399 0.8664454339426917 1.0 1.0 40 P35250,P15927,O60934,Q9UQ84,Q9NRF9,P18074 6 |
| Interactome of polycomb repressive complex 2 prc2 0.4131183450280434 0.14996876795066 0.8807892561130828 1.0 1.0 3 Q9NYF8 1 |
| Dna replication 0.3410438379886107 0.1485007315105879 0.8819476086943316 1.0 1.0 27 P24941,P35250,Q13416,P15927,Q9Y619,Q14566,P33991,Q07864 8 |
| Circadian rhythm genes 0.2742007031900194 0.1465794188609078 0.8834639995648599 1.0 1.0 41 Q13547,P23246,P43490,Q9Y2W1,Q03164,Q13330,Q9BWF3,Q9UNS1,Q06210,P16220,P54802,Q8WXF1 12 |
| Male infertility 0.3515774666709742 0.1441927402396108 0.8853482734882774 1.0 1.0 18 Q15165 1 |
| Rac1pak1p38mmp2 pathway 0.3505031174883705 0.1428922255811281 0.8863752986526041 1.0 1.0 16 O14920,Q05397 2 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.297479516572995 0.136580526255352 0.8913623700320676 1.0 1.0 37 O14920,P31751,P23588,Q05397 4 |
| Hedgehog signaling pathway wp4249 0.3998639918395122 0.1290082329124076 0.8973511343486611 1.0 1.0 3 Q13618,Q9UMX1 2 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.257160957762111 0.1270669142572462 0.8988874377530236 1.0 1.0 43 O14920,P67809 2 |
| Nucleotide excision repair 0.3432513233183465 0.1171543297028089 0.9067377572347636 1.0 1.0 18 P35244,P35250,P15927,Q9NRF9,P18074,Q07864 6 |
| Pilocytic astrocytoma 0.3907092809504701 0.115868070459075 0.9077571012970048 1.0 1.0 3 P62993 1 |
| Thermogenesis 0.3283586281987195 0.1068985712614604 0.9148694466654588 1.0 1.0 28 O43772 1 |
| 3q29 copy number variation syndrome 0.3218987563423723 0.0993874980315589 0.9208306087412734 1.0 1.0 9 O95684,P61088,Q09161,Q13177 4 |
| Interleukin11 signaling pathway 0.3289145081347717 0.0972599158911447 0.9225199875194916 1.0 1.0 12 P62993,P16220,O14920 3 |
| Hepatitis b infection 0.3346952591015552 0.0958168227436603 0.9236660562170356 1.0 1.0 23 O14920 1 |
| Methylation pathways 0.3634818089085373 0.0830605951709239 0.9338033580330454 1.0 1.0 3 P31153,Q9NZL9 2 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.5271923861318915 0.0744811658890035 0.9406275269801574 1.0 1.0 2 P55265 1 |
| Neural crest differentiation 0.3102657341972227 0.0733126308708443 0.9415573407670748 1.0 1.0 9 O14641 1 |
| Dna irdouble strand breaks and cellular response via atm 0.3275483959094601 0.0721086626664973 0.9425154323633425 1.0 1.0 23 Q92878,O60934,Q9UQ84 3 |
| Mitochondrial complex i assembly model oxphos system 0.3233219321104407 0.0711205887591997 0.9433017822009986 1.0 1.0 26 Q8IUX1,Q96CU9,O43676,Q9P0J0,Q9NX14,Q9NPL8,Q16718,O96000,Q7L592,P03886 10 |
| Tca cycle aka krebs or citric acid cycle 0.3199301827594004 0.0603863150306571 0.9518479577902884 1.0 1.0 15 P48735 1 |
| Bdnftrkb signaling 0.2990980532476287 0.0582881922823838 0.9535190727183902 1.0 1.0 8 P62993,Q15334 2 |
| Hippoyap signaling pathway 0.3087385243114521 0.0423554910350006 0.9662153094925984 1.0 1.0 3 Q13043,Q92597 2 |
| Breast cancer pathway 0.3179299040001228 0.0414154968646055 0.9669646586853604 1.0 1.0 22 P62993,O60934,P31751,O14641 4 |
| Dna damage response only atm dependent 0.3173309918339397 0.0403072413773372 0.9678481806880228 1.0 1.0 20 P62993,P61586,O14641,P25054,P31751 5 |
| Regulation of actin cytoskeleton 0.2919444615910415 0.038082725092784 0.9696217246974062 1.0 1.0 34 Q8NEB9,P35241,P61586,P41240,O75116,P25054,Q9UQB8,Q05397,Q14155 9 |
| Wntbetacatenin signaling pathway in leukemia 0.2790064647839374 0.0369420161961403 0.9705312385160614 1.0 1.0 5 P25054,P49841,P14923,P48729 4 |
| Nanoparticle triggered regulated necrosis 0.4381373215499751 0.0332158793779277 0.9735024351973134 1.0 1.0 2 Q13546 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.2992567621159786 0.0316360440648154 0.9747622987598156 1.0 1.0 12 Q86UE4,O14641 2 |
| Hedgehog signaling pathway wp47 0.4208021753908983 0.029868101340715 0.9761722459361226 1.0 1.0 2 Q9UMX1 1 |
| Calcium regulation in cardiac cells 0.3134052090684139 0.0289242588561531 0.9769249979443522 1.0 1.0 22 P62942,P20020,P05026 3 |
| Malignant pleural mesothelioma 0.2608390905418211 0.024287464356359 0.9806233121774924 1.0 1.0 64 Q4VCS5,Q96T88,Q13257,P49137,Q13177,Q02241,O14641,P25054,P24941,Q08722,Q13043,O15294,P62993,P08195,P16220,P31751,P42224,P23588,Q8NE86,Q05397 20 |
| Ras and bradykinin pathways in covid19 0.2074829931972853 0.0232386025856931 0.981459946502963 1.0 1.0 4 Q99829,P61586,Q13464 3 |
| Mitochondrial complex ii assembly 0.3116927260367158 0.0230661191396653 0.981597531501462 1.0 1.0 2 P21912 1 |
| Liver x receptor pathway 0.3096532970768245 0.0230456450632103 0.9816138631096584 1.0 1.0 2 O00767 1 |
| Pdgf pathway 0.2987869302629337 0.0195664232457 0.9843892490712548 1.0 1.0 14 P62993,P00403,P61586 3 |
| Il6 signaling pathway 0.283486827804977 0.0173406739066252 0.9861648373893226 1.0 1.0 10 Q13547,P62993 2 |
| Hepatocyte growth factor receptor signaling 0.284085313919327 0.0117824125984153 0.9905992124103278 1.0 1.0 11 Q05397 1 |
| Eukaryotic transcription initiation 0.2837524606427912 0.011266238652886 0.9910110322797596 1.0 1.0 11 P13984,P52434,P18074 3 |
| Oxidative damage response 0.23103096291255 0.0046404050327546 0.996297505756354 1.0 1.0 5 P12004,O95429,O95551,P42574 4 |
| Endometrial cancer 0.2847574265994335 0.0007725463851417 0.9993835972281058 1.0 1.0 13 P62993,P31751 2 |
|
|
